M D T and post M D T surveillance
The treatment of leprosy should be as recommended in the WHO Chemotherapy report3. There is a tendency to develop more complex treatment regimens and to treat for longer periods with regular bacteriological surveillance. This, however, is unnecessary. Treatment should continue to the standard recommended WHO MDT, using fixed duration and passive follow-up.
Re-treatment of monotherapy patients
Relapse in MB patients who have received only dapsone monotherapy is likely to be a main source of new cases. The re-treatment of such patients must be considered. This applies only to MB cases and the treatment advised is the standard MB MDT for 24 doses. These patients should not be put on the active treatment register while undergoing MDT treatment, unless they are shown to have relapsed.
MAINTAINING A REFERRAL SYSTEM
A referral system must be maintained which ensures that there are mechanisms in place for the proper diagnosis and treatment of new cases. This will vary from country to country depending on the existing systems and may mean greater or less centralization of expertise. The system must be sustainable. Systems which are already in place for other services may be the most sustainable, for example for dermatology or tuberculosis. It is important that such systems are properly integrated and that they are not independently-run parallel programmes. Systems which provide only leprosy expertise may be more difficult to sustain, except in very large countries.
Prevention of disability and rehabilitation
Programmes for the prevention of disability and rehabilitation should have been developed but they may be given a low priority because of the intensive activities of an MDT programme. The size of the The diabetic foot From the paper in this issue on 'Hand and foot sepsis in Libyan diabetic patients' (Bosseri and Gill, page 232) it would appear that the pattern of such complications resulting from diabetes in Africa may differ from that seen in the West.
Three factors contribute to foot complications in diabetic patients: (i) peripheral sensory, motor and autonomic neuropathy; (2) peripheral vascular disease, principally macrovascular occlusion; and (3) reduced resistance to infection.
In the UK, sensory neuropathy is the main primary factor in the causation of foot lesions. In a smaller problem must be estimated and staff retrained. In some countries these activities may be carried out by departments other than the health department. An intersectoral approach is needed which is community based and which can provide physical, social, psychological, economic and vocational rehabilitation.
Networking between countries
As the disease becomes rarer it will be necessary for countries to share resources and expertise in leprosy. Networks will have to be developed between countries to facilitate this interchange and to cope with patients who migrate.
Funding
It is inevitable that funding for leprosy will be reduced as the disease is given a lower priority compared to other health problems. However, programmes must be carefully planned and appropriately resourced to cover issues listed above. Lower priority should not mean no priority. number of patients this is complicated by peripheral vascular disease. As in leprosy, the foot lesions resulting from peripheral neuropathy fall roughly into three types': (1) due to burns or direct trauma on the dorsum of the foot; (2) due to shoe pressure on the dorsum of clawed toes, between the toes or on the sides of the feet; and (3) due to pressure from weight bearing and sometimes trauma on the plantar surface. In leprosy and in diabetes plantar lesions resulting from areas of high pressure during walking or weight bearing occur irrespective of the thickness of the sole of the foot. The relatively low incidence of this type of lesion in the Libyan patients is interesting. It is possible that the high incidence of lesions on the dorsum or sides of the feet may be due to pressure from ill fitting footwear. Many of the lesions at different sites can be prevented by appropriate protective footwear1x2.
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Infection usually enters secondarily through a preceding lesion, an ulcer, a skin crack or an area of ischaemic gangrene and often spreads rapidly due to poor tissue resistance, especially if there is a degree of ischaemia. It is rare in the UK to see primary infection unrelated to neuropathy or ischaemia. In this series from Libya, several cases of primary foot infection unassociated with neuropathy, ischaemia or reported trauma are reported. This may be related to poor diabetic control or forgotten trauma but it was not possible to obtain information about this.
The high incidence of hand infections is surprising. Peripheral neuropathy affecting the hands is not often seen in the UK and is not a factor in hand infections. In the Libyan series, 25% of the patients with hand infection are reported to have signs of neuropathy. In
Hand and foot semis in Libyan diabetic patients
The study of hand and foot sepsis in diabetic patients seen in Tripoli, Libya, which is published in this issue (Bosseri and Gill, page 232), points out the well-known association with diabetic neuropathy and, to a lesser extent, with peripheral vascular disease. The problem was frequent, 7.4% of the patients surveyed having suffered an episode. The retrospective nature of the study yields no information on mortality, but morbidity was significant. No information is given on the standard of diabetic control at the time of the incidents, or of the time after trauma/onset of symptoms before medical care was sought. It is known that lack of outpatient diabetes education is a risk factor for amputation'; poor control of hyperglycaemia and delay in seeking treatment for wounds and apparently small lesions were significant factors leading to amputations in diabetic patients seen in Addis Ababa2. During 18 years (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) of the 2250 patients registered in the Diabetic Clinic at Yekatit 12 Hospital, Addis Ababa, 43 (1.9%) required an amputation at diagnosis or during the course of diabetes mellitus2. The male to female ratio was 2.1; eight patients had type 1 and 35 type 2 diabetes. Diabetic peripheral neuropathy was the underlying condition in at least 21 of the 43 patients; only five cases of ischaemic gangrene were seen. Twelve of the 43 refused operation and died of sepsis; three others had sloughing of a digit having refused amputation. Ten had amputations of a toe and 12 had a below knee leg amputation. Two had an above elbow arm amputation and three a finger amputation.
Hand sepsis was surprisingly common in the report from Libya, with 25 of 60 patients reporting hand involvement, 75%, however, the cause of the hand infection is not clear and may again be related to poor diabetic control or unreported trauma. a third of them with neuropathy (see Table 2 , page 232). Neuropathy is unusual in the hand in patients with diabetes, seen only in a few patients with extensive manifestations in the legs. Serious infections in the hand are much less common than in the foot in Western countries, a pattern also noted in Addis Ababa, at Ieast among patients who had needed an amputation*.
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Published information from African countries also mainly concerns foot lesions implying that hand lesions are less common there, too3s4. Before reporting a high incidence of 'hand sepsis' as a feature of a diabetic population, more precise definition of what is meant is required. This implies a prospective study in which the duration before presentation and the extent or depth of lesions and the tissue involved (skin and/or subcutaneous tissues, muscle, and/or bone) is carefully documented, as well as the criteria for diagnosis of neuropathy and the standard of diabetic control.
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